Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

People who are more materialistic often expect life changes from buying things, leading to more debt and credit misuse.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Minoxidil effectively treats female pattern hair loss.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Commercial hair loss websites promote Propecia by making men feel insecure about baldness and suggesting it's a medical issue needing treatment.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

PCOS increases sexual pain distress in infertile women.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

Genetics and nutritional deficiencies are key factors in premature graying of hair.

More knowledge about the risks of performance-enhancing agents leads to less use in north-western Saudi Arabia.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

SLE patients often face depression and anxiety due to physical changes, with African-American and Hispanic patients having higher unmet psychological needs.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.